Both in Pharmaceuticals
Cronos Group Inc. Common Share vs Korsana Biosciences
Over the past year CRON returned +18.5% and KRSA returned −4.6%; their daily moves had a correlation of -0.02.
CRON +18.5% KRSA −4.6%Growth of $1, one year, split-adjusted
| Metric | CRON | KRSA |
|---|---|---|
| Price | $3.72 | $30.43 |
| Market cap | $1.37B | $1.39B |
| Today | +5.98% | −0.43% |
| 1 month | +14.8% | −3.9% |
| 6 months | +44.7% | — |
| Year to date | +41.4% | — |
| 1 year | +51.8% | — |
| Revenue growth (YoY) | +59.5% | — |
| Gross margin | 65.8% | — |
| Net margin | 45.4% | — |
| P/E (TTM) | 19.6× | — |
| Price / sales | 5.3× | — |
| Net cash | $797.0M | — |
| Dividend yield | — | — |
| Volatility (60d) | 31.4% | — |
| Short % of float | 2.1% | 1.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).